🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Anthem argues for 60 days to save merger with balky Cigna

Published 05/08/2017, 05:56 PM
Updated 05/08/2017, 06:00 PM
© Reuters. The office building of health insurer Anthem is seen in Los Angeles, California
CI
-
ELV
-
AET
-

By Tom Hals and Diane Bartz

WILMINGTON, Del./WASHINGTON (Reuters) - Health insurer Anthem Inc (N:ANTM) asked a Delaware judge on Monday to give it more time to try to win approval for a merger with rival Cigna Corp (N:CI), which is seeking to end the deal and collect a $1.85 billion break-up fee.

Anthem asked Vice Chancellor Travis Laster of Delaware's Court of Chancery to grant a 60-day preliminary injunction that would prevent Cigna from terminating the $54 billion deal that would create the largest U.S. health insurer.

Laster said after about five hours of arguments that he would rule as soon as possible.

The U.S. Justice Department and 11 states sued to stop the proposed transaction and won in both district court and an appeals court. Anthem wants the injunction while it pursues an appeal to the U.S. Supreme Court.

Anthem attorney Glenn Kurtz of White & Case told the Delaware court on Monday that he hoped the U.S. Supreme Court would decide before July if it would take the case.

Kurtz also said that Anthem would try to negotiate a solution with the Justice Department's Antitrust Division once the Trump administration's officials were in place.

Laster expressed reservations about allowing the deal to be terminated but said it was "a long shot" for Anthem to succeed in winning merger approval.

Kurtz presented documents that he said showed Cigna, including Chief Executive David Cordani, failed to help close the deal as required. Kurtz said Cigna refused to help craft a divestiture package to allay antitrust concerns and was unhelpful in the district court fight.

"If this case is not a breach of best efforts, then I'm not sure that 'best efforts' has any meaning at all," said Kurtz, who called Cigna's actions "unprecedented."

Cigna's attorney argued that it was Anthem that had breached the merger agreement by pursuing a failing antitrust strategy.

"Anthem drove this transaction into a regulatory ditch and had Cigna tied up in the back seat," said William Savitt of Wachtell, Lipton, Rosen & Katz.

Regardless of Laster's ruling on the injunction, litigation will continue over the $1.85 billion breakup fee. Kurtz said Anthem believes Cigna owes it for damages.

The fight takes place as Republicans seek to repeal and replace the Affordable Care Act, often called Obamacare, which had brought big changes in the insurance business.

© Reuters. The office building of health insurer Anthem is seen in Los Angeles, California

Many insurers have lost money on Obamacare, and some of Cigna's largest competitors, including Aetna Inc (N:AET), have largely left the market.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.